Genentech shareholders sued Roche Investments USA, claiming its $42 billion offer for the remaining 44% of Genentech shares it does not own, at $86.50 a share, is not enough, in San Jose Federal Court.
Categories / Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Additional Reads
-
-
Texans head to the polls for high-stakes US Senate primary February 17, 2026